Skip to content

Drug interactions

Dolutegravir + Elivaldogene autotemcel

Severity: Major

Dolutegravir and Elivaldogene autotemcel: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Antiretroviral drugs can interfere with lentiviral transduction during manufacturing of this gene therapy. Dolutegravir present during mobilization or apheresis could compromise the product.

What this interaction means in plain words

Dolutegravir and Elivaldogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Antiretroviral activity inhibits lentiviral vector transduction of harvested cells.

What to do

Stop dolutegravir at least one month before mobilization, allow for elimination, and keep it stopped until apheresis is complete. Plan alternative HIV control with specialists.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dolutegravir and Elivaldogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dolutegravir with Elivaldogene autotemcel?

MediHelp rates the interaction as major. Dolutegravir and Elivaldogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Antiretroviral drugs can interfere with lentiviral transduction during manufacturing of this gene therapy. Dolutegravir present during mobilization or apheresis could compromise the product.

How serious is the interaction between Dolutegravir and Elivaldogene autotemcel?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop dolutegravir at least one month before mobilization, allow for elimination, and keep it stopped until apheresis is complete. Plan alternative HIV control with specialists.

What other medicines interact with Dolutegravir?

MediHelp also lists interactions of Dolutegravir with, for example, Dofetilide, Aluminum hydroxide, Atidarsagene autotemcel. The full list is on the Dolutegravir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in